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Snail1Although an in vitro 3D environment cannot completely mimic the in vivo tumor site, embedding tumor cells in a
3D extracellular matrix (ECM) allows for the study of cancer cell behaviors and the screening of anti-metastatic
reagents with a more in vivo-like context. Here we explored the behaviors of MDA-MB-231 breast cancer cells
embedded in 3D collagen I. Diverse tumor environmental conditions (including cell density, extracellular acidity,
or hypoxia as mimics for a continuous tumor growth) reduced JNKs, enhanced TGFβ1/Smad signaling activity,
induced Snail1, and reduced cortactin expression. The reduced JNKs activity blocked efﬁcient formation of
invadopodia labeled with actin, cortactin, or MT1-MMP. JNKs inactivation activated Smad2 and Smad4, which
were required for Snail1 expression. Snail1 then repressed cortactin expression, causing reduced invadopodia
formation and prominent localization of MT1-MMP at perinuclear regions. MDA-MB-231 cells thus exhibited
less efﬁcient collagen I degradation and invasion in 3D collagen I upon JNKs inhibition. These observations sup-
port a signaling network among JNKs, Smads, Snail1, and cortactin to regulate the invasion of MDA-MB-231 cells
embedded in 3D collagen I, which may be targeted during screening of anti-invasion reagents.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
During metastasis, cancer cell migration and invasion are dynami-
cally regulated by coordinated signaling pathways that respond to the
extracellular matrix (ECM) or soluble factors of the tumor microenvi-
ronment [1]. Invasion involves degradation of the ECM via formation
of invasive morphological features including invadopodia, which sense
the ECM around the edges of a cell and involve adhesion-dependent
signaling activities [2,3]. The formation of invasive features involves dy-
namic actin remodeling. c-Src-mediated cortactin phosphorylation
causes activation of Arp2/3, consequently leading to actin branching
and polymerization at lamellipodia and invadopodia [4]. Therefore,
cell migration, invasion, and the formation of invasive morphological
features could be targets to prevent cancer metastasis. However,
investigating the mechanisms behind certain cell behaviors is criticaly, College of Pharmacy, Seoul
l 151-742, Republic of Korea.for developing more effective targeted-therapies. While informative,
studies investigating the effects of extracellular cues on cell functions
in two dimensional (2D) conditions may not relate to the in vivo or in
situ behaviors of cancer cells, because cancer lesions are exposed to a
3D microenvironment [5,6].
Cell behaviors, including migration and invasion, are often investi-
gated in a 2D environment. Although the signiﬁcance of the tumor
microenvironment in promoting tumorigenesis and metastasis has
been suggested in many in vitro and in vivo studies [7], studies evaluat-
ing cells in a 2D environment are limited tomimic in vivo tumor lesions,
whereas embedding cells in a 3D environment allows for the cells to re-
ceive and respond to environmental cues like in vivo situation. The
tumor microenvironment includes ECM proteins, neighboring cells,
and soluble factors consisting of growth factors, cytokines, and
chemokines, which inﬂuence cancer cell function and behavior and
have been targeted for clinical treatment [8]. Various environmental
stressors including ECM stiffness, extracellular acidity, and intratumoral
hypoxia can affect cancer cells and neighboring stromal ﬁbroblasts and
inﬂammatory cells eventually leading to metabolic alterations and the
stimulation of mitogenic and survival signaling pathways [9].
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ability to mimic in vivo tumor lesions, whereas embedding cells in a
3D environment allows for the cells to receive and respond to environ-
mental cues like in an in vivo situation. Although an in vitro 3D environ-
ment cannot completely mimic the in vivo tumor site, studying the
mechanistic behaviors of cancer cells in a 3D environment is beneﬁcial
for clinical and pharmaceutical purposes.
c-Jun N-terminal kinases (JNKs) consist of 3 isoforms and are acti-
vated by various extracellular cytokines and chemical or radiant stresses
[10,11]. JNKs phosphorylate Ser63 of c-Jun leading to its stabilization
and transcriptional activation [12,13]. Activated c-Jun can regulate
expressions of diverse molecules related to tumor metastasis [14].
Snail1 is a transcriptional repressor to regulate diverse E-box motif-
containing molecules for tumor metastasis including E-cadherin [15,
16]. Such Snail1- and Snail2/Slug-mediated suppression of E-cadherin
is generally accepted as oneof the hallmarks of epithelial–mesenchymal
transition (EMT), which converts almost static epithelial cells to motile
and invasive mesenchymal cells during tumor metastasis [17].
In this study, we evaluatedwhether and how the invasive behaviors
of MDA-MB-231 breast cancer cells embedded in a 3D collagen I gel
could be regulated. Exposing theMDA-MB-231 cells to various environ-
mental parameters during culture in the 3D collagen gels decreased
JNKs signaling activity (i.e., decreased Ser63 phosphorylation of c-Jun,
pS63c-Jun), activated TGFβ1/Smads signaling, enhanced Snail1 expres-
sion levels, and reduced cortactin expression levels. Inactivation of the
JNKs signaling pathway led to the Smad2/Smad4-activation-mediated
expression of Snail1, which in turn suppressed cortactin. As a result,
invadopodia formation was less efﬁcient within the 3D collagen I gels,
further with cortactin and/or membrane type I matrix metalloprotein-
ase (MT1-MMP) localization at perinuclear regions, leading to less
migration and invasion. Therefore, the signaling network consisting of
JNKs, Smads, Snail1, and cortactin was revealed to modulate migration
and invasion of the MDA-MB-231 cells embedded in 3D collagen I gel.
2. Materials and methods
2.1. Cells, plasmids, and siRNAs
MDA-MB-231, MDA-MB-436, MDA-MB-468, T47D, BT549, Hs578T,
and MCF7 breast cancer cells were obtained from the American Type
Culture Collection and grown in complete RPMI-1640 (JBI, Daegu,
Korea) supplemented with 10% fetal bovine serum (FBS, Life Technolo-
gies, Carlsbad, CA) and antibiotics (Life Technologies). DNA plasmids:
pcDNA3-DN-JNK1, pcDNA3-Flag-Snail1 WT (a kind gift from Dr. Semi
Kim, KRIBB, Korea), pmCherry-MT1-MMP (a kind gift from Dr. Philippe
Chavrier, CNRS, France), or pcDNA3.1-GFP-cortactin WT (a kind gift
from Dr. Laszlo Buday, Semmel Weis University, Hungary) were
transfected into cells 1 day before the cells were embedded in 3D colla-
gen type I gel (PureCol, Advanced BioMatrix, San Diego, CA). Some cells
were co-transfectedwith ﬂuorescein conjugated SignalSilence® control
siRNA and SignalSilence® SAPK/JNK siRNA (Cell Signal Technology,
Danvers, MA) or On-Target plus Smartpool siRNA duplexes designed
to target human Snail1 (NM_005985, Dharmacon, Lafayette, CO). As a
negative control, cells were transfected with nonspeciﬁc siRNA pool
(Dharmacon). All cDNA vectors or siRNA transfections were performed
with Lipofectamine™ 2000 (Invitrogen) according to the manufac-
turer's instructions.
2.2. Polydimethylsiloxane device fabrication
A polydimethylsiloxane prepolymer (PDMS, Sylgard 184, Dow
Corning, Midland, MI) was made using a 10:1 (w/w) mixture of PDMS
base and curing agent. The PDMS prepolymer was cast against themas-
ter and thermally cured to obtain a negative replica-molded piece. After
separation from themaster, 4- or 8-well chambers were punched out of
the molded PDMS with an 8 mm biopsy punch. The PDMS devices andglass coverslips were cleaned with residue-free tape and a N2 gas air
gun, and then treated with oxygen plasma for 45 s to form covalent
bonding between them. To restore hydrophobicity to the PDMS after
plasma treatment, the devices were kept in a 60°C dry oven for at
least 24 h and sterilized by UV irradiation before use.
2.3. Antibodies and reagents
Antibodies and reagents were obtained from the following sources:
Sigma-Aldrich, 10× RPMI, anti-α-tubulin, anti-α-SMA, and anti-
vimentin; BD Biosciences, anti-cortactin mAb (4F11), anti-human
HIF-1α, and BD Matrigel™ Basement Membrane Matrix; Cell Signal
Technology, anti-E-cadherin (24E10), anti-Snail1 mAb (L70G2), anti-
Smad2/3, anti-phospho-Smad2, anti-phospho-Smad4, anti-pS63c-Jun,
anti-c-Jun, and anti-phospho-MAPKAPK-2 (Thr222) antibodies;
Millipore, anti-MT1-MMP mAb (MAB3328) and anti-cortactin (p80/85)
antibodies (4F11), and Alexa Fluor® 488; Santa Cruz Biotechnology,
Inc., anti-JNK rabbit pAb, anti-Arp2 (H-84), and mDia1 (H-58);
Invitrogen, diaminophenylindole (DAPI), and rhodamine phalloidin;
Jackson ImmunoResearch Laboratories, HRP-conjugated secondary anti-
bodies; LC Labs, SP600125, U0126, and SB203580; Advanced BioMatrix,
PureCol type I bovine collagen solution (3.2 mg/ml); PeproTech,
TGFβ1; R&D Systems, anti-E-cadherin and anti-TGFβ(1,2,3) antibodies
(MAB1835).
2.4. Cell culture in three-dimensional type I collagen gels
3D collagen type I gels were prepared using PureCol type I bovine
collagen (Advanced BioMatrix, Poway, CA) in 24-well culture plates.
Collagen Imixtures (2.5 mg/ml)were prepared by adding the appropri-
ate volumes of 10× reconstitution buffer (260 mM sodium bicarbonate
and 200mMHEPES) and 10× RPMI (SigmaAldrich). To adjust the pH of
the collagen solution, an ice-cold solution of 2 N NaOH was used for
pH 7.2–7.4. The neutralized collagen solution was incubated on ice for
3–5 min to allow the pH to equilibrate, and then the solution was
centrifuged for 3 min at 10,000 ×g at 4°C to eliminate air bubbles. The
bottom layer of 2.5 mg/ml collagen I was made in each well with 30 μl
and allowed to gel by incubating for 30 min at 37°C. A top layer was
loaded onto the bottom layer using a cell suspension containing
300,000 cells that had been mixed with 150 μl of neutralized collagen
mixture and allowed to gel by incubation for 30 min at 37°C. In case of
a lower density, 100,000 cells/well were embedded. 3D Matrigel (BD
Biosciences, 10 mg/ml) or a mixture of Matrigel and collagen I gel (at
a ratio of 5 mg/ml and 1.25 mg/ml, respectively) was also prepared
using the same procedure as above. A medium with 10% FBS was
then overlaid every day on top of the gel with or without SP600125
(50 μM) for 24–72 h to accelerate the 3D culture-mediated c-Jun inhibi-
tion. In cases, a pH-controlledmedium (using ﬁltered 1 NHCl)with 10%
FBS was replenished every day for 2 days after the embedding, or
hypoxic condition at 5% O2 was applied for 4 h after the embedding, in
parallel to the normal condition.
2.5. Immunoblotting
Whole cell lysates from2D cultureswere prepared, as described pre-
viously [18]. Cells embedded into 3D collagen I and cultured for 3 days
were transferred into ice-cold 1.7 ml tubes and centrifuged at 2500 ×g
for 1 min to remove residual medium. Cell pellets within collagen I
masses were washed with ice-cold PBS and then homogenized using
truncated pipette tips (3 times × 20min on ice) in amodiﬁed RIPA buff-
er (50mMTris–HCl, pH 7.4, 150mMNaCl, 1% NP-40, and 0.25% sodium
deoxycholate) with a protease inhibitor cocktail (GenDepot, USA). The
extracts were centrifuged for 30min at 15,000 ×g and 4°C. The samples
were normalized for equal protein loading in standard immunoblots via
α-tubulin levels.
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Cells were cultured within polydimethylsiloxane prepolymer
(PDMS) glass coverslips and ﬁxed directly with 4% formaldehyde for
30 min at room temperature (RT), and subsequently treated with
100 mM glycine to quench residual aldehyde groups. The cells
transfected with GFP or GFP-tagged cortactin for 24 h were embedded
into 3D collagen I gels for another 24 h with treatment of either DMSO
or SP600125 (50 μM). After PBS washings, cells were permeabilized
for 30 min with 0.5% Triton X-100 at RT and blocked for 2 h with PBS
in 3% BSA. In cases, cells were stained with either ﬂuorescein-labeled
phalloidin (Molecular Probes, 1:250) or Alexa Fluor® 488-labeled
anti-cortactin (Millipore, 1: 200) at 4°C overnight. In cases, FITC-
collagen I (Sigma, 1 mg/ml) was mixed with collagen I mixtures
(2.5 mg/ml) at a 1:8 ratio, prior to embedding cells into the gels conse-
quently for visualization of collagen I ﬁbers. Cells were then washed
with washing buffer (130 mM NaCl, 13 mM Na2HPO4, 3.5 mM
NaH2PO4, pH 7.4). Nuclei were counterstained with DAPI. Confocal im-
ages were captured at 37°C using a confocal microscope with a Nikon
Plan-Apochromat 60×/1.4 N.A. oil objective (Nikon eclipse Ti; Nikon,
Japan) and analyzed using the NIS software (Nikon) or IMARIS imaging
software (Bitplane AG, Zurich, Swiss). Confocal z-stack images obtained
from NIS software were reconstructed into 3D images with the aid of
the IMARIS software, Easy 3D modes. The visualization or quantitative
colocalization analysis of certain images was performed using
the ImarisColoc and surpass module. The graphs were presented as
mean ± standard deviation from three independent experiments.
2.7. Time-lapse cell images
Time-lapse cell images of 3D type 1 collagen gels were captured at
37°C with IX81-ZDC (Olympus, Japan) for 24 h, using cells embedded
in 3D collagen gels in the absence (control) or presence of 50 μM
SP600125 on PDMS glass coverslips. In some cases, cells expressing
GFP or mCherry protein were imaged with a confocal Nikon eclipse Ti
microscope with a Nikon Plan-Apochromat 60×/1.4 N.A. oil objective.
All microscopes were equipped with a Chamlide Incubator system
(Live Cell Instrument (LCI), Korea), and an environmental chamber
mounted on the microscope was maintained constantly at 37°C, 5%
CO2 and 95% humidity.
2.8. ECM degradation assay using DQ™-collagen I
MDA-MB-231 cells (1.5 × 105 cells/ml per well in the PDMS device)
transiently transfected with mCherry-tagged MT1-MMP or mCherry
vector for 48 h were embedded into 3D gels consisting of collagen
type I (2.5 mg/ml, PureCol) and DQ™-collagen type I (2.5 mg/ml, Life
Technologies) at a volume ratio of 10:1. After 30 min incubation at
37°C, each gel in the devices was overlayed with 200 μl RPMI-1640
medium with DMSO (control) or SP600125 (50 μM) treatment. Then
2–4 h later, the z-stack images of up to 3 μm with a 0.7 μm spacing
were obtained for 4 h with a 10 min interval, using the Nikon Plan-
Apochromat 60×/1.4 N.A. objective of a Nikon eclipse Ti microscope.
2.9. RT-PCR and quantitative real time PCR (qPCR)
Total RNA was extracted from cells in 3D collagen gels using TRIzol
(Invitrogen) according to the manufacturer's protocol. One microgram
of total RNA was reverse transcribed using amﬁRivert Platinum cDNA
Synthesis master mix (GenDepot, USA), and qPCR was performed
using DreamTaq Green PCR Mater Mix (Thermo Scientiﬁc) and the
7900HT Fast real time system (Applied Biosystems). Primers for Snail1,
cortactin, JNK1, Smad2/3, Twist, Snail2/Slug and GAPDHmRNAs were de-
signed using Primer3 software. Primer sequences were as follows:
CDH1 (E-cadherin), forward 5′-TGCCCAGAAAATGAAAAAGG-3′ and re-
verse 5′-GTGTATGTGGCAATGCGTTC-3′; CTTN, forward 5′-CCTGGAAATTCCTCATTGGA-3′ and reverse 5′-CACAAAATCAGGGTCGGTCT-3′; JNK1,
forward 5′-TTGGAACACCATGTCCTGAA-3′ and reverse 5′-ATGTACGGGT
GTTGGAGAGC-3′; Snail1, forward 5′-GGTTCTTCTGCGCTACTGCT-3′ and
reverse 5′-TAGGGCTGCTGGAAGGTAAA-3′; Smad2, forward 5′-CGAAAT
GCCACGGTAGAAAT-3′ and reverse 5′-CCAGAAGAGCAGCAAATTCC-3′;
Smad4, forward 5′-CCCCAGAGCAATATTCCAGA-3′ and reverse 5′-GGCT
CGCAGTAGGTAACTGG-3′; Twist, forward 5′-GGAGTCCGCAGTCTTACG
AG-3′ and reverse 5′-TCTGGAGGACCTGGTAGAGG-3′; slug, forward
5′-GGGGAGAAGCCTTTTTCTTG-3′ and reverse 5′-TCCTCATGTTTGTGCA
GGAG-3; GAPDH, forward 5′-GAGTCAACGGATTTGGTCGT-3′ and reverse
5′-GACAAGCTTCCCGTTCTCAG-3′.2.10. ChIP analysis
TheMDA-MB-231 cells were embedded in 3D collagen and cultured
in the absence (control) or presence of SP600125 (50 μM) for 3 days.
Cell culture medium was removed and the cells in 3D collagen were
ﬁxed with 3.7% formaldehyde for 30 min at RT and washed with
100 mM glycine and PBS. The ﬁxed cells were transferred to 1.5 ml
centrifuge tubes on ice andwashedwith ice-cold PBS includingprotease
inhibitor cocktails and centrifuged at 5000 ×g for 1 min at 4°C. The
supernatants were removed and the cells were lysed with SDS buffer
(1% SDS, 10 mM EDTA, 50 mM Tris, pH 8.1 and 1 mg/ml each of
aprotinin, leupeptin, and pepstatin A) on ice. Samples were sonicated
6 times on ice (30 s each time at intervals of 1 min) to homogenize
cells in the collagen gel, and spun down at 15,000 ×g at 4°C for 3 min
to remove collagen prior to collection of the supernatants. Aliquoted su-
pernatants (400 μl)were sonicated on ice to fragmentDNA to 200–1000
base pair length and centrifuged for 10 min at 15,000 ×g and 4°C. The
sonicated samples were diluted 10-fold in ChIP buffer (0.01% SDS, 1.1%
Triton X-100, 1.2 mM EDTA, 16.7 mM Tris, pH 8.1, 167 mM NaCl, and
1 mg/ml each of aprotinin, leupeptin, and pepstatin A). The diluted
chromatin solutions (400 μl) were incubated with 10 μl antibody of
anti-pS63c-Jun, anti-Smad2, anti-Smad4, or anti-Snail1 antibody at 4°C
with rotation overnight. Before immunoprecipitation, 400 μl of chroma-
tin solutionwas saved (input chromatin). The immune complexeswere
collected by adding 50 μl of salmon sperm DNA/protein A and G-beads
and rotating for 4 h at 4°C. The beads were recovered by brief centrifu-
gation, washed with low salt complex wash buffer (0.1% SDS, 1% Triton
X-100, 2 mM EDTA, 20 mM Tris–HCl, pH 8.1, 150 mM NaCl), high salt
complex wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM
Tris–HCl, pH 8.1, 500 mM NaCl), LiCl immune complex buffer (0.25%
LiCl, 1% NP-40, 1% sodium deoxycholate, 1 mM EDTA, 1 mM EDTA, 10 mM
Tris–HCl, pH 8.1), and TE buffer (20 mM Tris, 1 mM EDTA, pH 8.0),
with a brief centrifugation between each wash to recover the beads.
The immune complexes were eluted from the beads by the addition of
500 μl 1% SDS in 0.1MNaHCO3 to the bead pellet, vortexing and rotating
at 4°C for 10 min. To reverse the cross-linking process, 200 mM NaCl
was added to the eluates before incubation at 65°C overnight. Incuba-
tion at 55°C for 1 h was performed in 10 mM EDTA, 40 mM Tris–HCl,
pH 6.5, and 2 ml of 10 mg/ml proteinase K. DNA was recovered by
phenol/chloroform extraction and ethanol precipitation. Promoter
sequences were detected in immunoprecipitated and input DNA by
PCR using the following primers: Snail1, forward primer 1 (Snail1-p1)
5′-TCCAAACTCCTACGAGGC-3′ and reverse primer 1 5-′GAAGAAGTGG
CAACTGCT-3′, forward primer 2 (Snail1-p2) 5′-GGAGACGAGCCTCCGA
TT-3′ and reverse primer 2 5′-CAGTAGCGCAGAAGAACCACT-3′, and for-
ward primer 3 (Snail1-p3) 5′-AGCACACTTCCCTTTGCATT-3′ and reverse
primer 3 5′-CACCCGTTCCTTCCCTTATC-3′; primer for negative control
regions (Snail1-n), forward 5′-CGTAAACACTGGATAAGG-3′ and reverse
5′-GGAAACGCACATCACTGG-3′; primer for the CTTN, forward primer
(cortactin-p) 5′-TCTGCAGACTCGCCACAG-3′ and reverse 5′-CAGGCACC
AGGCTCTACTTC-3′; primer for negative control regions (cortactin-n),
forward 5′-AGTGTTATGATTACAGGC-3′ and reverse 5′-ATAGAGCACA
GCGAAGAC-3′.
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Fig. 1.Diverse tumormicroenvironmental factors caused JNK signaling inactivation, Snail1 induction, and cortactin suppression. (A to D)Whole cell lysateswere prepared fromMDA-MB-
231 cells embedded in 3D collagen gels with the normal serum-containing culture medium refreshment every day for up to 5 days (A) and up to 4 days of culture at lower or higher
densities (B), in different-pH medium that was replenished every day (C), in hypoxic condition for 4 h (D). N depicts normoxia and H depicts hypoxia. Cell lysates were processed for
standard immunoblotting to analyze the indicated molecules. The relative ratio values of band intensities were presented after normalizations to total protein (in case of phospho-
protein) orα-tubulin. Data represent three independent experiments. (E) Snail1, pS63c-Jun, and cortactin were immunostained for different regions (e.g., core tumor region or marginal
invasive regions) of each patient tissue case (magniﬁcations of 100×, 200×, or 400×). Red arrows indicate invasive margins especially with strong nuclear pS63c-Jun, weak Snail1, and
strong cortactin stainings.
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EMSA was performed using nuclear extracts from MDA-MB-231
cells embedded in 3D collagen gels. Cell pellets without cytosolic partswere resuspended in hypertonic buffer C (50 mM HEPES pH 7.9,
50 mM KCl, 300 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 0.1 mM PMSF,
and 10% glycerol). The nuclear extracts were then centrifuged for
10 min at 12,000 ×g. The oligonucleotide (28-mer, 5′-TAGCGCTTAGCC
2041M.-S. Lee et al. / Biochimica et Biophysica Acta 1843 (2014) 2037–2054AGCTGCGGGCGGACCC-3′) corresponding to the E-box of the human
cortactin promoter was end-labeled with [γ-32P]ATP using T4 polynu-
cleotide kinase and was puriﬁed on a Nick column (Amersham
Pharmacia Biotech, Buckinghamshire, UK). The nuclear protein (15 μg)
was mixed with 4 μl of concentrated incubation buffer (10 mM Tris–
HCl, pH 7.5, 100 mM NaCl, 1 mM DTT, 1 mM EDTA, 4% glycerol, and
0.1 mg/ml sonicated salmon sperm DNA), and the hypertonic buffer
was added to make up the ﬁnal volume to 20 μl. After pre-incubation
at room temperature (RT) for 15 min, the labeled probe (400,000 cpm)
was added to the nuclear extracts and incubated for an additional 50
min at RT. To ensure the speciﬁc binding of the labeled oligonucleotide
to nuclear protein, a competition assaywas carried out with the 100 nM
unlabeled cold oligonucleotide. After the incubation, 0.1% Bromophenol
Blue (2 μl) was added, and Snail1–DNA complexes were separated from
the unbound free probe by electrophoresis on 6% nondenaturing poly-
acrylamide gel in 0.5 × TBE (Tris/borate/EDTA) buffer (90 mM Tris
base, 90 mM boric acid, and 0.5 mM EDTA, pH 8.0) at 70 V for 2 h.
Gels were dried and exposed to X-ray ﬁlm. For the antibody supershift
assay, 1 μl of Snail1mouse antibody or normalmouse IgG (Cell Signaling
Technology, Inc.) was incubated with the nuclear protein extract for
30 min on ice, prior to addition of the reaction mixture containing
radiolabeled nucleotides.
2.12. Immunohistochemistry
Normal and tumor breast tissues were obtained from patients in the
Yonsei University Hospital (Seoul, Korea) with informed consent. Clini-
cal and biological information was available for the tissue samples.
Whole-mount slides of human clinical sampleswere used for validation
of immunoblotting data by immunostaining for Snail1, pS63-c-Jun, and
cortactin, as explained previously [19].
2.13. Statistical methods
Band intensities of the Western blots or RT-PCR were measured
using Image J to compare each other, which were calculated to give rel-
ative ratio values after normalization to total protein (in cases of
phospho-proteins), α-tubulin, or GAPDH levels. Student's t-tests were
performed for comparisons of mean values to determine signiﬁcance.
p values b0.05 were considered signiﬁcant.
2.14. Supplemental information
Supplemental information is found at the Journal website.
3. Results
3.1. Diverse tumor microenvironmental factors revealed a correlation
among JNKs inactivation, Snail1 induction, and cortactin suppression
MDA-MB-231 breast cancer cells in 3D collagen gel with 10% serum
under different environmental parameters to promote continuous
tumor cell growth showed reduced Ser63 phosphorylation levels of
c-Jun (i.e., pS63c-Jun), although proliferating cell nuclear antigen
(PCNA) was not changed to indicate no signiﬁcant cytotoxicity during
the culture (Fig. 1A). Concomitantly, Snail1 expression increased but
cortactin expression decreased, although E-cadherin, Snail2/Slug and
c-Jun levels were generally unchanged (Fig. 1A). The increased Snail1
and decreased pS63c-Jun and cortactin levels depended on cell densities,
since continuous culture at a high cell density showed more dramatic
changes, compared with less cells (Fig. 1B). We then found that extra-
cellular acidity caused the same effect (Fig. 1C). Acute hypoxia with an
HIF1α induction showed also the same effect (Fig. 1D). Furthermore, a
breast tumor tissue showed Snail1 immunostaining in a random distri-
bution around the distal and proximal edges of a large invasive tumor
nest (Fig. 1E, top). Whereas staining of Snail1 was weak (marked witharrows), nuclear pS63c-Jun and cytosolic cortactin stainings were more
obvious at the invasive tumor edges of another tumor tissue case
(Fig. 1E, bottom). These interestingly suggest an exclusive relationship
between Snail1 and cortactin for invasion.
3.2. JNK inhibition caused Snail1 induction and cortactin suppression,
leading to reduced migration and invasion in 3D collagen gels
We next examined the morphology and behavior of MDA-MB-231
cells embedded in 3D collagen gels. Pharmacological JNKs inhibition
by SP600125 treatment caused an elongation in cellular morphology
(Fig. 2A), with a higher length/width ratio (Fig. 2B). However, MDA-
MB-231 cells embedded in 3D Matrigel or a mixture of Matrigel and
collagen (at a 4:1 w/w ratio) did not show the elongation (Fig. S1A),
indicating an ECM-speciﬁc morphological effect. RT-PCR and immuno-
blotting after JNK inhibition showed that Snail1 and TwistmRNA expres-
sion increased, but cortactin mRNA decreased, although Snail2/Slug
mRNA level was not changed (Fig. 2C). More importantly, the Snail1
mRNA levels were not correlated with E-cadherin (CDH1) mRNA or
E-cadherin protein levels, indicating that the Snail1 might not be linked
to E-cadherin suppression (Fig. 2C). These gene expression changes
occurred in the cells embedded only in collagen gel but not Matrigel
or the mixture of Matrigel and collagen I (Fig. S1B). Phosphorylated-
ERKs and -p38were not involved in the effects on alterations in gene ex-
pression, because there were no similar changes upon JNK inhibition
(Figs. 2D, S1C and D). SP600125 treatment did not alter actin nucleator
Arp2 and mDia expression levels (Fig. S1D). Thus, the morphological
elongation by JNK inhibition might be correlated with the alterations
in expression levels of Snail1 and cortactin. We next checked the
relationship between the cortactin level and the cellular length by ex-
amining whether exogenous cortactin (over)expression abolished the
SP600125 treatment-mediated elongation. Whereas cells transfected
with GFP alone were elongated by the SP600125 treatment, cells
transfected with GFP-cortactin did not show the SP600125 treatment-
mediated effects (Fig. 2E).
Live cell imagingwasused tomonitormorphological changes and/or
motility upon treatment with or without SP600125. SP600125-treated
cells exhibited relatively-steady locations and morphological protru-
sions during time-lapse imaging,whereas control cells showed dynamic
growth of invasive protrusions and locomotion (Fig. 2F and Supplemen-
tary Movies 1 and 2) leading to more consistent migration in 3D
collagen gels (Fig. 2G). Therefore, it is possible that JNK inhibition-
mediated effects may control migratory and invasive properties of
MDA-MB-231 cells in 3D collagen gel.
3.3. JNK inhibition caused less efﬁcient formation of actin and cortactin-
enriched invadopodia
When we costained cells with cortactin and F-actin, which are
known to localize at the invadopodia [20], images to stain Alexa
488®-tagged anti-cortactin (green) and phalloidin (red) clearly showed
more yellowish-overlapped spots (i.e., invadopodia) in control vehicle-
treated cells (Fig. 3A) than in SP600125-treated cells (Fig. 3B). The less
overlapped spots in SP600125-treated cells than in control cells was
demonstrated by quantiﬁcation of merged yellowish spots in slice
images (Fig. 3C). We also observed dynamic turnover in GFP-cortactin
localization along the frequently-altered boundaries of control cells,
whereas its localization in SP600125-treated cells was steady and not
at the cellular boundary (Fig. S2, Supplementary Movies 3 and 4).
Further, collagen I degradation by the cells was monitored using DQ
™-collagen I that was mixed into the 3D collagen I gels. Whereas
MDA-MB-231 cells treated with DMSO showed more green ﬂuorescent
spots for the collagenase activity around leading and base/cell body
area, the SP600125-treated cells showed much less (Fig. 3D, Supple-
mentary Movies 5 and 6).
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2043M.-S. Lee et al. / Biochimica et Biophysica Acta 1843 (2014) 2037–2054Human breast cancer cell lines cultured on 3D-laminin-rich ECM
gels are grouped into four different morphological classiﬁcations:
round, mass, grape-like, and stellate [21]. When diverse breast cancer
cell lines were tested for the JNK inhibition-mediated effects in the 3D
collagen I environment, mass (T-47D and MCF-7) or grape-like (MDA-
MB-468) cells did not showmorphological elongation, whereas stellate
cells (MDA-MB-436 and MBA-MB-231 cells) showed morphological
elongation with a loss of cortactin- and actin-colocalized spots (yellow
spots) upon JNK inhibition (Fig. 3E). The colocalization of F-actin and
cortactin in MDA-MB-436 cells was decreased by SP600125 treatment
(Fig. 3F). Further, like MDA-MB-231 cells, MDA-MB-436 cells decreased
pS63c-Jun, increased Snail1 expression, and decreased cortactin expres-
sion upon JNK inhibition (Fig. 3G). Other basal tumor type cells like
BT-549 and Hs578T also showed such morphological elongations and
a signaling axis of c-Jun/Snail1/cortactin upon JNK inhibition (Fig. S3).
However, MDA-MB-231 and MBA-MB-436 cells did not show altered
expressions of EMT markers, including E-cadherin, α-smooth muscle
actin (α-SMA), or vimentin (Fig. 3H), although the JNK inhibition
caused Snail induction (Fig. 3G). These observations support that cer-
tain breast cancer cells (i.e., stellate-grouped cells) could become less
invasive by the signaling link between pS63c-Jun, Snail1, and cortactin,
irrelevantly to the EMT process.
When Snail1 was overexpressed, cortactin was reduced but
pS63c-Jun was not changed (Fig. 4A), suggesting c-Jun upstream of
Snail1. Overexpression of Snail1 (marked by cotransfected mCherry
plasmid) decreased endogenous cortactin-enriched spots, compared
with mCherry alone-transfected control or Snail1-untransfected (i.e.,
only greenish) cells showing more frequent cortactin-positive spots at
the tips and base/cell body area (Fig. 4B, C). Following transfection
with siSnail1, cortactin (CTTN) mRNA increased and JNK1 mRNA was
not changed (Fig. 4D). The JNK inhibition-mediated decrease in
cortactin expression was abolished by knockdown of Snail1 (Fig. 4E).3.4. The relationship among pS63c-Jun, Snail1, and cortactin occurred at the
transcriptional level
We next tested whether these molecular changes occurred at the
transcriptional level by chromatin immunoprecipitation (ChIP) assay.
There found AP1 binding sites in the human Snail1 gene promoter re-
gion and E-box binding sites in the human cortactin (CTTN) gene pro-
moter region (Fig. 5A). Chromatin extracts, prepared cells in 3D
collagen gel in the presence of SP600125 treatment with enhanced
Snail1 and reduced pS63c-Jun and cortactin levels (Fig. 5B), were
immunoprecipitated with either anti-pS63c-Jun or anti-Snail1 antibody
(Fig. 5C, D). PCR product representing region p1 of the Snail1 promoter
(Snail1-p1), but not a control region (i.e., a non-AP1-binding site, Snail1-
n), was only detected from pS63c-Jun-immunoprecipitated chromatin
(Fig. 5C), indicating a binding of pS63c-Jun to the Snail1 promoter region.
However, theremay be other factors involved in Snail1 transcription be-
cause reduced pS63c-Jun correlated with enhanced Snail1mRNA levels
(see below). Meanwhile, chromatin precipitated with anti-Snail1 anti-
body showed more PCR product representing region p of the CTTN
promoter (cortactin-p), but not from a control region in the promoter
(cortactin-n), in SP600125-treated cells (Fig. 5D). Snail1, a transcriptionalFig. 2. Inhibition of JNK signaling caused Snail1 induction and cortactin suppression, leading to less
of elongated morphology of MDA-MB-231 cells in 3D collagen gels after pharmacological inhibiti
imaging software. * depicts a statistical signiﬁcance at p = 1.65 × 10−6 (B). (C) Western blot
SP600125 for different times. P depicts a positive control of HCT116 colon cancer cell extracts. The
(in case of phospho-protein), α-tubulin, or GAPDH. (D) Immunoblots were performed using who
concentrations for 24 h. (E) Cells were transiently transfected with GFP or GFP-tagged cortactin (G
(Control, C) or presence of SP600125 (SP), before imaging for rhodamine phalloidin for F-actin (re
sured using IMARIS software. * and ** depict statistical signiﬁcant and insigniﬁcant difference, resp
and treated with vehicle (DMSO, Control) or 50 μM SP600125. Arrowheads in the control conditio
showed dynamic migration for longer distances (Con, n = 7), but SP600125-treated cells exhibit
(Control) and 2 (SP600125-treated). The data represent three independent experiments.suppressor [22], could thus bind a promoter region of the CTTN gene and
suppress cortactin expression.
RT-PCR revealed that Snail1mRNAsweremore stable in control cells
(treated with actinomycin D alone) than cells treated with actinomycin
D and SP600125 together (Fig. 5E). Quantitative real time PCR (qPCR)
analysis showed that CTTNmRNAhad a half-life longer than 48 h in con-
trol cells, but a half-life of approximately 24 h in cells treated with both
actinomycin D and SP600125 (Fig. 5F). The half-lives of Snail1 and
cortactin proteinswere b6 h for Snail1 and≅12 h for cortactin, being in-
dependent of SP600125 treatment (Fig. 5G). In vitro binding of Snail1
protein from the nuclear extracts of MDA-MB-231 cells in 3D collagen
gels to the 5′ promoter of cortactin was analyzed by EMSA using the
region covering the E-box sequence as the probe. The probe binding
increased as more nuclear extracts were mixed (Fig. 5H, left panel).
The binding was abolished by cold probe incubation, and the complex
between the probe and Snail1 was conﬁrmed by a supershift when
anti-Snail1, but not normal IgG, was added (Fig. 5H, right panels).
pS63c-Junbinding to a Snail1 genepromoter region occurredwithout
SP600125 treatment. Thus, increased Snail1 transcript upon JNK inhibi-
tion indicated that another factor(s) could be involved in Snail1 tran-
scription. Snail1 mRNA increased but CTTN mRNA decreased in cells
cultured in 3D collagen gel, whereas Smad2 and Smad4 mRNAs were
not altered (Fig. 6A), indicating that cells embedded in 3D collagen gel
may secrete TGFβ1 leading to autocrine effects. However, immunoblot-
tings showed increased TGFβ1, Smad2, and Smad3 protein levels and
Smad2 phosphorylation (Fig. 6B). JNK inhibition or extracellular acidity
also enhanced TGFβ1 and Smad2 expression (Fig. 6C, D). Cells were
then analyzed for Snail1 and cortactin expression after transfection
with shRNA against GFP or each Smad. The JNK inhibition-mediated
changes in Snail1 and cortactin expression were blocked by Smad2 or
Smad4 knockdown, whereas Smad3 knockdown did not block the
changes (Fig. 6E). SP600125-treated cells showed Smad-binding ele-
ment in the Snail1 gene promoter region (Snail1-p3), as demonstrated
by RT-PCR ampliﬁcation of chromatin precipitated using anti-Smad2
or -Smad4 (but not -Smad3) antibodies (Fig. 6F), suggesting that
TGFβ1/Smad activity in MDA-MB-231 cells embedded into 3D collagen
gel might induce Snail1 transcription, following JNK inhibition.
3.5. JNK1 suppression or Snail1 expression caused the inverse relationship
between Snail1 and cortactin expression, and decreased invadopodia
formations
To avoid nonspeciﬁc effects by SP600125, cells were transfected
with GFP plasmids (to mark transfectants during imaging) together
with orwithout dominant-negative (DN) JNK1. DN-JNK1 expression re-
duced pS63c-Jun, enhanced Snail1, decreased cortactin expression
(Fig. 7A), and less actin-enriched spots (shown as peaks in the histo-
gram, Fig. 7B). When JNK1 was suppressed by siRNA introduction, the
relationship among JNK1, Snail1, and cortactin levels was similar to
that found in MDA-MB-231 cells continuously cultured in 3D collagen
gels with SP600125 treatment (Fig. 7C, D). Further, siJNK1-transfected
cells (marked with cotransfected GFP-tagged control siRNA as a green
spot marked with a white arrow [23]) showed reduced actin-enriched
spots, compared with untransfected neighboring cells (i.e., siJNK1-
negative cell without green spots, Fig. 7E).dynamicMDA-MB-231 cellmigration and invasionwithin 3D collagen gels. (A andB) Images
on of JNK signaling for 3 days were saved (A) and quantiﬁed to get length/width ratio using
or RT-PCR analysis from the cells embedded in 3D collagen gels and treated with 50 μM
relative ratio values of band intensities were presented after normalizations to total protein
le lysates of cells embedded in 3D collagen gels and treated with SP600125 (SP) at different
FP-Cort) for 2 days and the cells were then embedded into 3D collagen I gels in the absence
d) and GFP ﬂuorescence. The cellular length in themultiple representative images was mea-
ectively. (F and G) Time-lapse microscopic images of the cells embedded in 3D collagen gels
n indicate dynamically and invasively growing tips (F). Tracking analysis of each control cell
ed decreased motilities (SP, n = 7). These snap images were from Supplementary Movies 1
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regions but not membrane boundaries
When actin and collagen ﬁbers were stained or visualized, control
cells showed clear ECM-degraded areas (yellow arrowheads), whereas
SP600125-treated cells showed no clear ECM-degraded areas, as shown
as yellow arrowheads especially in the xz plane (Fig. 8A).We then imaged
the invadopodia using a differentmarker, matrixmetalloproteinaseMT1-
MMP [20].When cells transfectedwithmCherry-taggedMT1-MMPwere
embedded into 3D collagen gel before double-staining for MT1-MMP
(red) and actin (green), MT1-MMP was overlapped with actin-enriched
spots, as demonstrated by frequent overlapping throughout the xz or yz
cut-stacks (Fig. 8B). MDA-MB-231 cells embedded in 3D collagen gelsControl
SP600125
Actin
Actin
Control
SP600125
A
B
C
Fig. 3. JNK inhibition-mediated effects among different breast cancer cell lines. (A–C) Confoca
Control, A) or SP600125 (B). Confocal images in each channel (green for cortactin and red for
(i.e., colocalization) throughout each plane at the same depth from the ventral boundary we
red (highest signal intensity) to dark blue (lowest signal intensity) over the cells in gray. The n
and SP600125-treated (SP, n=5) cells to present as a quantitative graph atmean± standardd
withmCherry vector alone for 48 h and then embedded into 3D collagen I gelsmixedwith DQ-c
(control) or SP600125 treatment. Arrowheads at each color for a separate cell show green ﬂuor
collected at a 10min interval, but snap images at irregular intervalswere selectively shown for a
cells embedded in3D collagen I gelswith vehicle (Cont, n=11) or SP600125 (SP, n=8) treatm
DQ-collagen I degradations were visually counted and represented as mean ± standard devia
cancer cells embedded in 3D collagen were analyzed for F-actin (red), cortactin (green), an
MDA-MB-436 cells (F) as shown in Fig. 3C, or immunoblotting for the indicated molecules (Gdid not exhibit changes in MT1-MMP expression, unlike cortactin
(Fig. 6C and D). When mCherry-tagged MT1-MMP was transfected
into cells, the vehicle-treated control cells showed dynamic turnover
of MT1-MMP-positive spots along peripheral and/or central regions of
the cells and frequent alterations in morphological boundaries, and
led to enhanced cellular locomotion (Fig. 8C, Supplementary Movie 7).
However, SP600125-treated cells showed a steady morphology and
moreMT1-MMP around perinuclear regions than along cellular bound-
aries (Fig. 8D, Supplementary Movie 8). Cells cotransfected with
mCherry-MT1-MMP and GFP-cortactin showed dynamic translocation
of spots doubly-positive for cortactin and MT1-MMP (i.e., yellowish
spots) along the cellular boundaries (arrowheads, Fig. 8E, Supplementa-
ry Movie 9), whereas the cortactin and MT1-MMP double-positiveCortactin
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2045M.-S. Lee et al. / Biochimica et Biophysica Acta 1843 (2014) 2037–2054spots in SP600125-treated cellsweremore localized around the nucleus
than cell boundaries (Fig. 8F, Supplementary Movie 10). The collagen I
degradation of cells transfected with mCherry-tagged MT1-MMP was
then examined using DQ™-collagen I. Although the control cells with-
out SP600125 treatment showed dynamic ECM degradation spots
costainedwithMT1-MMP along base/cell body area (bluemarked, Sup-
plementary Movie 11), SP600125-treatment reduced the degradation
(Fig. 8G and H, Supplementary Movie 12).
4. Discussion
This study revealed that the environmental parameters around
tumor cells including cell density, extracellular acidity, and hypoxia
could cause JNK signaling inactivation (i.e., decreased c-Jun phosphory-
lation), TGFβ1/Smad signaling activation, Snail1 induction, and
cortactin suppression. This signaling network led to stabilized localiza-
tion of cortactin and MT1-MMP (both proteins are invadopodia
markers) at perinuclear regions rather than at cell membrane bound-
aries, resulting in the reduced formation of actin and cortactin-
enriched invadopodia along the edges of cells embedded in 3D collagen
gels. Furthermore, more frequent morphological change and displace-
ment of MDA-MB-231 cells in 3D collagen I gels, compared withSP600125-treated and thereby Snail1-induced MDA-MB-231 cells
(Figs. 2 and 8), indicate that the cellularmigration and invasion through
3D ECM environment were attenuated by the JNK inhibition-mediated
effects. In this study, the use of MDA-MB-231 cells in 3D collagen I
more accurately can reﬂect growth of a tumor in vivo, only in the con-
text of comparing to growth of cells onmonolayer 2D culture. Although
the tumormicroenvironment, including other cells, was not completely
available in this experimental assay setup, it might certainly suggest an
aspect of tumor cells with autocrine behaviors in 3D, comparedwith 2D
environment.
We have compared the invasive features of MDA-MB-231 breast
cancer cells embedded in 3D collagen gels, 3D Matrigel, or a mixture
of Matrigel and collagen I (at a 4:1 w/w ratio). Cells embedded in 3D
Matrigel or the mixture of Matrigel and collagen I did not exhibit the
JNK, Snail1, and cortactin linkage demonstrated in cells embedded in
3D collagen gels. A speciﬁc communication between MDA-MB-231
cells and surrounding ECM types appeared to regulate invasive behav-
iors. Among the diverse morphologically-different breast cancer cells
[21], only stellate cells (MDA-MB-231 and MDA-MB-436 with basal B
tumor classiﬁcation) showed JNK activity-dependent morphological
elongation and signaling network change, leading to a decreased
invadopodia formation, indicating that invasiveness in a certain type
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2046 M.-S. Lee et al. / Biochimica et Biophysica Acta 1843 (2014) 2037–2054of breast cancer cells may be regulated by the JNK, Smads, Snail1, and
cortactin network. Meanwhile, mass-grouped cells (T-47D and MCF-7
with luminal tumor classiﬁcation) that have been established from
IDC tumors [21] did not show the JNK-dependent effects on Snail1 in-
duction and cortactin suppression. Grape-like-group cells (MDA-MB-
468 with basal A tumor classiﬁcation and MDA-MB-453 with luminal
tumor classiﬁcation) did not show the JNK-dependent effects. There-
fore, it may be likely that a breast cancer cell type with basal B tumor
classiﬁcation and stellate morphology in 3D could be inﬂuenced by
JNK activity for Snail1 induction and cortactin suppression. Consistentwith increased Snail1 stains approaching the central necrotic area of
ductal carcinoma in situ (DCIS) [24], we here observed cases showing
that Snail1 was randomly expressed in clinical breast tumor tissues
rather than being localized around the invasive edges, although the
cases were rare at approximately 10% rate. The JNK, Smads, Snail1, and
cortactin signaling network may be related to a speciﬁc breast tumor
population. MDA-MB-231 and MDA-MB-436 cells are triple-negative
breast cancer cells [negative for estrogen receptor (ER), progesterone
receptor (PgR), and HER2 ampliﬁcation [21]] and further negative for
E-cadherin (Fig. 3H). Thus it may be likely that the JNK activity-
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2047M.-S. Lee et al. / Biochimica et Biophysica Acta 1843 (2014) 2037–2054dependent Snail1 induction and cortactin suppression may be limited
to a breast cancer cell population without ER, PgR, HER2, and E-
cadherin expression.
Snail1 induces also EMTby suppressing E-cadherin [15,25], being as-
sociated with the metastatic potential of inﬁltrating ductal carcinoma
(IDC) [26,27]. However, in DCIS, Snail1 is also localized in the nucleus,
being correlated with higher tumor grade and proliferation rather
than with migration [24], and expressed at similar levels in both the
tumor and the normal zone of DCIS tissues [19]. Therefore, Snail1
expression may have differential effects on metastasis depending on
the local invasiveness. It is well-known that a small population of breast
tumor cells is motile even around the margins of metastatic breast can-
cer models [28,29]. In this study, Snail1 induced by JNKs inhibition was
not correlated with E-cadherin (CDH1) mRNA suppression, and MDA-
MB-231 and MDA-MB-436 cells did not show basal E-cadherin expres-
sion. Instead, Snail1 bound the promoter of cortactin (CTTN) and nega-
tively regulated its expression. Snail1 may thus have different
downstream targets leading to less metastatic potential in a speciﬁc
breast cancer cell population, like DCIS (an early noninvasive breast
cancer), rather than leading to E-cadherin suppression and enhanced
migration and invasion. Indeed, hypoxia-mediated Snail1 expression
in breast cancer cells slightly decreases migration of MDA-MB-231
cells but increases migration of MDA-MB-468 cells, following a partial
hypoxia-induced EMT phenotype [24], being consistent with theobservations in this study; the phospho-c-Jun/Snail1/cortactin linkage
in MDA-MB-231 cells was correlated with JNK-inhibition-mediated
less formation of invadopodia in 3D condition, but the linkage was ab-
sent in MDA-MB-468 cells due to no basal c-Jun phosphorylation and
no change in cortactin level (Fig. 3G). Therefore, it might be likely that
Snail1 expression might not be always leading to enhanced migration
if the EMT phenotype to suppress E-cadherin is not completely accom-
panied, as shown in this study that the expression pattern of E-cadherin
was irrelevant to that of Snail1 (Figs. 2C, 3G and H).
In controlMDA-MB-231 cells in 3D collagen gels, pS63c-Jun bound to
the promoter of the Snail1 gene, indicating that active c-Jun may regu-
late basal Snail1 transcription. However, in the conditions where
pS63c-Jun decreased via the inﬂuence of extracellular environments,
Snail1 mRNA and protein levels increased, indicating that proteins
others than c-Jun could be involved in Snail1 transcription. Inhibiting
JNK activity in E12.5 lung explants causes TGFβ1-activated Smad2 phos-
phorylation and gene expression changes for branchingmorphogenesis
[30]. c-Jun associates with the oncoprotein, Ski, to suppress Smad2
transcriptional activity [31]. It may thus be likely that JNK inhibition is
coordinated with TGFβ1-activated Smad2/4 binding to the Snail1 gene
promoter region. Although it is reported that TGFβ1 regulates cross-
talk between Smad signaling and JNK signaling during EMT of rat peri-
toneal mesothelial cells [32], there are other reports that c-Jun activity
is inversely correlated with TGFβ1 and Smad signaling activity [33,34],
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2048 M.-S. Lee et al. / Biochimica et Biophysica Acta 1843 (2014) 2037–2054in agreement with this study. In 2D condition, Snail1-mediated EMT re-
sults in enhanced invasion [35]. The collagen receptor discoidin domain
receptor 2 (DDR2) post-transcriptionally stabilizes Snail1 via c-Src and
ERKs activations, and facilitates metastasis of breast cancer cells [36].
In the current study, however, enhanced Snail1 transcription did not in-
volve ERK activity or E-cadherin suppression, but rather led to cortactin
suppression and less migration potential. TGFβ1/Smad3-mediated
Snail1 induction in pancreatic cancer cells promotes invasion on 2D col-
lagen I and causes cell scattering in 3D collagen I via an increase inMT1-MMP expression [37], although we found in the current study that
breast cancer cells in 3D collagen I adopted Smad2 for Snail1 induction,
eventually leading to cortactin suppression and aberrant localization of
MT1-MMP for a less efﬁcient metastatic potential. This study reveals
that MDA-MB-231 cells embedded in 3D collagen gels and exposed to
various microenvironmental parameters inactivate the JNK/c-Jun
signaling pathway, which was in turn coordinated with the TGFβ1/
Smad2/4 activation to promote Snail1 transcription. This effect was
observed only in cells embedded in 3D collagen gels, but not in cells
A
Cortactin
Smad3
B
Smad2/3
p-Smad2
Smad2
S d3
1.0 3.1 2.8 8.6 4.1
2 3 4 51day
Snail1
GAPDH
Smad2
-tubulin
TGF 1
2 3 4 51day
ma
1.0 3.4 2.9 7.8 0.8
1.0 3.5 3.1 3.3 1.3
Collagen I Collagen I
C
MT1-MMP
Smad2/3 Smad2Smad3
1.0 1.1
D
Smad2/3
p-Smad2
Smad2
Smad3
1.0 2.9 2.6
-tubulin
TGF 1
SPCon
1.0 4.9
1.0 2.8
MT1-MMP
TGF 1
1.0 4.6 5.7
1.0 1.6 2.5
1.0 1.0 1.0
Collagen I
E
Cortactin
1.0 0.2 0.4 0.4 0.6 0.1 0.0 0.0
Collagen I 
(media pH) 7.2 7.0 6.8
-tubulin
-tubulin
Snail1
+ + ++SP
shGFP shSd2shSd3 shSd4
Collagen I
1.0 1.6 0.7 0.0 0.2 0.6 0.4 0.1
F
IP:Smad2 IP:Smad3 IP:Smad4
Binding primer
Smad binding element
Snail1
+1
GTARTU’5
p3
-855 -695
Snail1-p3
Input
Collagen I
+
Collagen I
+
Collagen I
+SP600125
Fig. 6. Enhanced TGFβ1/Smad signaling in 3D collagen gel was responsible for increased Snail1 transcription upon JNK signaling inhibition. (A–D) RT-PCR (A) or immunoblotting analysis
(B–D) for the indicatedmolecules inMDA-MB-231 cells cultured in3Dcollagenup to 5 days (A andB) or for 24 h (C andD), treatedwith vehicle (DMSO, Con) or SP600125 (SP) (C), orwith
culture media replenished everyday at different pH (D). (E) Immunoblots using lysates from the cells treated with DMSO (−) or SP600125 (+) after transient transfection of shGFP or
shRNA against each Smad protein (shSd). (F) Schematic presentations of the Smad-binding element in the promoter regions of the Snail1 gene (top) and ChIP assay using chromatin im-
munoprecipitates using anti-Smad antibodies (bottom)prepared fromwhole lysates of cells treatedwith vehicle (−) or SP600125 (+) in3D collagen gels. The relative ratio values of band
intensities were presented after normalizations to total protein (in case of phospho-protein) or α-tubulin. The data represent three independent experiments.
2049M.-S. Lee et al. / Biochimica et Biophysica Acta 1843 (2014) 2037–2054cultured in 2D environments, 3D Matrigel, or 3D mixture of collagen I
and Matrigel, indicating a speciﬁc communication existing between
the 3D microenvironment and the cells. The reduced invasiveness fol-
lowing cortactin suppression by Snail1 enhanced in 3D cultures
surrounded with collagen I, but not with Matrigel, suggests the ECM-
speciﬁc effects.
The observations in this current study may represent a unique pop-
ulation of breast tumor cells that shows a less effective invasion via the
JNK inactivation-mediated effects, given that a small population ofbreast tumor cells is motile even around the margins of metastatic
breast cancermodels [28,29]. There are many previous reports claiming
that Snail1 leads to enhanced migration and invasion [38,39]. In addi-
tion, PDGF-BB-mediated Snail1 expression in bone marrow-derived
mesenchymal stem cells enhances MT1-MMP expression and invasion
[40]. Breast cancer cells expressing Snail1 inoculated atop of the chorio-
allantoic membrane of chicks causeMT1-MMP expression and invasion
[41]. Culture of ﬁbroblasts in 3D collagen I results in a positive correla-
tion between Snail1 and cortactin expressions for an invasive capacity
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current study in the effects of 3D collagen I-mediated Snail1 expression
on MT1-MMP expression and invasion might be due to different cell
types and/or cell culture systems.
We demonstrated here that Snail1 could suppress cortactin expres-
sion. Cortactin is an actin binding protein at actin-enriched invasivemorphological features, such as invadopodia [43]. Cortactin binds to
Arp2/3 actin nucleator complex during actin branching [44]. Thus, the
cortactin suppression might reduce activities for actin branching pro-
cesses (and thus lead to a thin cellularmorphology), and presumably re-
fractory mDia or formin-mediated ﬁbrillar actin polymerization might
lead to cellular elongations. Snail1 could bind to the cortactin (CTTN)
2051M.-S. Lee et al. / Biochimica et Biophysica Acta 1843 (2014) 2037–2054promoter and suppressed cortactinmRNA and protein levels onlywhen
JNK was inactivated in the cells embedded in 3D collagen gel. In addi-
tion, cortactin and MT1-MMP invadopodia markers were dynamicallylortnoC
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2052 M.-S. Lee et al. / Biochimica et Biophysica Acta 1843 (2014) 2037–2054(Fig. 3A) and 3D ECM degradation spots along cell length or base/body
(Fig. 8G), and were also costained with cortactin (Fig. 8E). Thus, the
invadopodia enrichedwith F-actin, cortactin, andMT1-MMP to degrade
surrounding collagen I were shown around ﬂank or base/cell body area
of the cells. It is also previously shown that MDA-MB-231 cells embed-
ded in 3D environment consisting of collagen I andMatrigel for 24–36 h
form invadopodia enriched with cortactin and MT1-MMP to degrade
collagen along the length of and the tips of invasive protrusion [45,
46]. However, it is suggested that invadopodial structures in 3D envi-
ronment can be different signiﬁcantly, depending on the cell typesand thematrixmodel used [45]. The difference in the invadopodia posi-
tion between the previous studies [45,46] and this current study may
thus be due to differences in matrix type used and in the imaging time
after the embedding (e.g., during invadopodia formation or matura-
tion), since our MDA-MB-231 cells were embedded into collagen I gels
only and imaged at 3–7 h after the embedding. Meanwhile, unlike on-
top 3D systemswhere cells were sandwiched between two ECM layers,
3D ECM-surrounded condition in this study might have cellular mor-
phologies more dynamic in z-stacks, so that the confocal images might
not have a clear focus on the invasive tips of cells. In addition to the
GFP-Cortactin/mCherry-MT1-MMP/Control
E
GFP-Cortactin/mCherry-MT1-MMP/SP600125F
Fig. 8 (continued).
2053M.-S. Lee et al. / Biochimica et Biophysica Acta 1843 (2014) 2037–2054very tip of leading edges of migratory cells in 3D conditions, cells em-
bedded in 3D ECM gels show invadopodia formation at the base or
branching sites of protrusions during invasive path generation
[47–50]. Therefore, it is suggested that the invadopodia promote ECM
degradation at the very tip of and behind the leading protrusions and/
or base of the cell body to generate andwiden a path for invasivemigra-
tion, when cells were embedded in 3D ECM conditions [51]. Thus, JNK
inhibition-mediated effects (cortactin suppression and perinuclear
localization of cortactin and MT1-MMP) decreased invadopodiaformation and invasion in 3D collagen gels. As suggested in previous
studies where Snail1 does not elicit a complete EMT [24] and that inva-
sion is not dependent on an EMT phenotype [52], Snail1-decreased cell
invasion in this study may be relevant to a speciﬁc breast cancer cell
population that is maintained locally noninvasive, and whose
noninvasiveness may be possible by Snail1-mediated suppression
and/or abnormal localization of cortactin and/or MT1-MMP, following
the JNK/c-Jun pathway inactivation via tumor cell communication
with the microenvironment.
2054 M.-S. Lee et al. / Biochimica et Biophysica Acta 1843 (2014) 2037–2054Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.05.007.
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